MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202647044224 A) filed by Novo Nordisk A/S, Bagsvaerd, Denmark, on April 7, for 'anti il-6 domain antibodies.'
Inventor(s) include Egebjerg, Thomas; Bjelke, Jais, Rose; Yang, Che; Reedtz-Runge, Steffen; Kopp, Katharina, Luise, Maria; Balantic-Nielsen, Emma; and Sassene, Philip, Jonas.
The application for the patent was published on April 17, under issue no. 16/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds (e.g. ISVDs, polypeptides, polypeptide derivatives) capable of binding to Interleukin-6 (IL-6) and their use in the treatment of inflammatory diseases such as, e.g. cardiovascular disease (CVD)."
The patent application was internationally filed on Sept. 11, 2024, under International application No.PCT/EP2024/075309.
Disclaimer: Curated by HT Syndication.
